Rema - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 242,456 | 190,025 | 164,458 | 204,095 | 250,119 | 270,945 | 311,620 | 350,284 |
| Profit before tax | -7,116 | -10,900 | 4,924 | 6,924 | -5,138 | 9,396 | 11,264 | 22,158 |
| Net profit | -7,116 | -10,900 | 4,924 | 6,924 | -5,138 | 9,396 | 10,442 | 18,469 |
| Equity | 238,233 | 227,333 | 232,257 | 239,181 | 233,949 | 243,344 | 253,693 | 261,851 |
| Liabilities | 11,607 | 28,932 | 19,986 | 29,064 | 33,960 | 28,617 | 27,581 | 9,995 |
| Non-current assets | 46,399 | 42,277 | 38,941 | 35,746 | 48,603 | 44,047 | 39,997 | 35,957 |
| Current assets | 203,441 | 213,988 | 213,302 | 232,499 | 219,306 | 227,914 | 241,277 | 235,889 |
| Total assets | 249,840 | 256,265 | 252,243 | 268,245 | 267,909 | 271,961 | 281,274 | 271,846 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 43,427 | 54,467 | 69,671 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -2.0% | -21.6% | -13.5% | +24.1% | +22.6% | +8.3% | +15.0% | +12.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -2.8% | -4.3% | 2.0% | 2.6% | -1.9% | 3.5% | 3.7% | 6.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -3.0% | -4.8% | 2.1% | 2.9% | -2.2% | 3.9% | 4.1% | 7.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -2.9% | -5.7% | 3.0% | 3.4% | -2.1% | 3.5% | 3.4% | 5.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -2.9% | -5.7% | 3.0% | 3.4% | -2.1% | 3.5% | 3.6% | 6.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 60,614 | 47,506 | 41,115 | 55,662 | 83,373 | 90,315 | 103,873 | 116,761 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Rema - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2022-04-25 | 2022-05-09 | 0.03 |
| 2022-02-17 | 2022-02-21 | 0.01 |
| 2022-01-27 | 2022-02-07 | 0.01 |
| 2021-11-16 | 2021-11-21 | 0.03 |
Rema - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Rema, UAB (code 132550213) is a private limited liability company engaged in wholesale of pharmaceutical and medical goods. In 2025, the company generated EUR 350.3K in revenue, up 12.4% year on year and 29.3% over two years. Net profit increased to EUR 18.5K from EUR 10.4K in 2024 and EUR 9.4K in 2023, while the profit margin improved to 5.3% from 3.4% in 2024 and 3.5% in 2023. Total assets at the end of 2025 were EUR 271.8K, broadly in line with EUR 281.3K in 2024 and EUR 272.0K in 2023. Equity stood at EUR 261.9K and liabilities at EUR 10.0K, indicating a very strong equity base and a debt-to-equity ratio of 0.04. The equity ratio was 96.3%, asset turnover 1.29x, ROE 7.0% and ROA 6.8%. Revenue per employee was EUR 116.8K, with profit per employee of EUR 6.2K.